1. Market Research
  2. > Pharmaceutical Market Trends
  3. > The Pharmaceutical Excipients Market by Products, Functionality, & by Route of Administration (Oral, Topical, Parenteral, Others) – Global Forecast to 2019

Pharmaceutical excipients are inactive ingredients used along with the active ingredients in a drug formulation. While excipients may have different functionalities, they generally do not affect the therapeutic action of the active ingredient. The demand for functional excipients is expected to record a strong growth in the forecast period due to its increased use in advanced drug delivery forms.

The global pharmaceutical excipients market is majorly driven by patent cliffs resulting in increased demand of generic drugs, emergence of novel excipients, and growing demand of functional excipients. Use of modern science like nanotechnology to impart novel functions to the excipients used for target specific functionality of the active ingredients is also expected to propel the market for pharmaceutical excipients during the forecast period.

The pharmaceutical excipients market in this report is broadly segmented by products, functionality, and route of administration. The market by products is segmented into organic and inorganic chemicals. The market by functionality is segmented into fillers & diluents, binders, suspension & viscosity agents, coatings, flavoring agents, disintegrants, lubricats & glidants, colorants, and preservatives, while the market by route of administration covers oral, topical, parenteral, and other excipients.

The global pharmaceutical excipients market is expected to grow at a CAGR of 6.7% during the forecast period of 2014 to 2019. Swelling utilization of parenteral products owing to rise in the global burden of chronic and lifestyle diseases and heavy investments by the pharmaceutical industry on the development of biologics has propelled the growth of this market. Moreover, development of new APIs is increasing the demand of excipients like solubilizers and disintegrants which will further drive the growth of this market.

While developed regions like North America and Europe will show a sluggish growth, emerging markets like Asia-Pacific and Rest of the World is expected to record a strong growth during the forecast period. Countries like India, China, and Brazil will majorly drive the growth of these emerging markets owing to rising number of companies from the developed regions outsourcing their excipients manufacturing activities to these regions due to low manufacturing and labor costs in these countries.

Some of the prominent players in this market include Ashland Inc. (U.S.), BASF SE (Garmany), The Dow Chemical Company (U.S.), Roquette (France), Colorcon, Inc. (U.S.), Avantor Performance Materials, Inc. (U.S.), FMC Corporation (U.S.), Evonik Industries (Germany), and Lubrizol Corporation (U.S.). Various strategies such as collaborations, expansions, and new product launches have helped these companies maintain their market share and grow in this competitive market.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the pharmaceutical excipients market. The report analyzes the pharmaceutical excipients market by products, functionality, and route of administration.
- Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the pharmaceutical excipients market.
- Market Development: Comprehensive information about the lucrative emerging markets by product, functionality, and geography.
- Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the pharmaceutical excipients market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the pharmaceutical excipients market.

Table Of Contents

The Pharmaceutical Excipients Market by Products, Functionality, and by Route of Administration (Oral, Topical, Parenteral, Others) - Global Forecast to 2019
TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 22
1.3.2 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY GEOGRAPHY 22
1.3.3 YEARS CONSIDERED IN THE STUDY 23
1.4 CURRENCY AND PRICING 23
1.5 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH APPROACH 24
2.2 MARKET SIZE ESTIMATION 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.4 MARKET SHARE ESTIMATION 28
2.5 KEY SECONDARY SOURCES 29
2.6 KEY DATA FROM PRIMARY SOURCES 30
2.6.1 KEY INDUSTRY INSIGHTS 31
2.7 ASSUMPTIONS FOR THE STUDY 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 38
4.1 GROWTH POTENTIAL OF THE PHARMACEUTICAL EXCIPIENTS MARKET 38
4.2 PHARMACEUTICAL EXCIPIENTS MARKET IN ASIA-PACIFIC 39
4.3 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 40
4.4 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT: GEOGRAPHIC MIX 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 43
5.2 MARKET SEGMENTATION 43
5.2.1 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT 43
5.2.2 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 44
5.2.3 PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION 44
5.3 MARKET DYNAMICS 45
5.3.1 DRIVERS 46
5.3.1.1 Growth of the global pharmaceuticals market backed by functional excipients 47
5.3.1.2 Patent cliffs driving the growth of excipients in the generics market 47
5.3.1.3 Advances in nanotechnology imparting new functions to pharmaceutical excipients 47
5.3.1.4 Emergence of new excipients for the pharmaceutical industry 48
5.3.2 RESTRAINTS 48
5.3.2.1 Declining RandD investments pose a long-term growth barrier for the market 49
5.3.2.2 Increased regulatory requirements leading to shortage of FDA-approved manufacturing sites 49
5.3.3 OPPORTUNITIES 50
5.3.3.1 Shifting focus of pharmaceutical manufacturing to emerging countries 50
5.3.3.2 Multi-functionality excipients are proving to be emerging areas of new product developments 51
5.3.4 CHALLENGES 51
5.3.4.1 Quality concerns demand greater transparency in supply chain 51
6 INDUSTRY TRENDS 52
6.1 INTRODUCTION 52
6.1.1 REGULATORY TRANSITION DRIVEN BY RISING NEED OF HIGH-QUALITY EXCIPIENTS 53
6.1.2 RISING DEMAND FOR NEW EXCIPIENTS AND EMPHASIS ON CO-PROCESSED EXCIPIENTS 54
6.1.3 DEMAND FOR EXCIPIENTS TO BE DRIVEN BY THEIR RISING NEED IN DIRECT COMPRESSION 54
6.2 PORTER'S FIVE FORCES ANALYSIS 56
6.2.1 THREAT OF NEW ENTRANTS 57
6.2.2 THREAT OF SUBSTITUTES 58
6.2.3 BARGAINING POWER OF SUPPLIERS 58
6.2.4 BARGAINING POWER OF BUYERS 58
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 58
6.3 VALUE CHAIN ANALYSIS 59
6.4 STRATEGIC BENCHMARKING 60
6.4.1 EXPANSIONS 60
7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT 62
7.1 INTRODUCTION 63
7.2 INORGANIC CHEMICALS 65
7.2.1 CALCIUM PHOSPHATES 67
7.2.2 CALCIUM CARBONATE 68
7.2.3 CALCIUM SULFATE 68
7.2.4 HALITES 69
7.2.5 METALLIC OXIDES 70
7.2.6 OTHERS 71
7.3 ORGANIC CHEMICALS 72
7.3.1 CARBOHYDRATES 74
7.3.1.1 Sugars 75
7.3.1.2 Actual sugars 77
7.3.1.2.1 Lactose 78
7.3.1.2.2 Sucrose 78
7.3.1.2.3 Dextrose (D-Glucose) 78
7.3.1.3 Sugar Alcohols 78
7.3.1.3.1 Sorbitol 79
7.3.1.3.2 Mannitol 80
7.3.1.3.3 Other Sugar Alcohols 80
7.3.1.4 Artificial Sweeteners 80
7.3.1.5 Starch 81
7.3.1.5.1 Modified Starch 82
7.3.1.5.2 Dried Starch 83
7.3.1.5.3 Converted Starch 84
7.3.1.6 Cellulose 85
7.3.1.6.1 Cellulose Ethers 87
7.3.1.6.2 Microcrystalline Cellulose 87
7.3.1.6.3 Cellulose Esters 88
7.3.1.6.4 CMC and Croscarmellose Sodium 89
7.3.2 PETROCHEMICALS 90
7.3.2.1 Glycols 91
7.3.2.1.1 Polyethylene glycol 93
7.3.2.1.2 Propylene glycol 93
7.3.2.2 Povidones 93
7.3.2.3 Mineral hydrocarbons 94
7.3.2.3.1 Petrolatum 95
7.3.2.3.2 Mineral waxes 95
7.3.2.3.3 Mineral oils 95
7.3.2.4 Acrylic polymers 95
7.3.2.5 Other Petrochemical Excipients 96
7.3.3 OLEOCHEMICALS 97
7.3.3.1 Fatty alcohols 98
7.3.3.2 Mineral stearates 99
7.3.3.3 Glycerin 100
7.3.3.4 Other Oleochemical Excipients 101
7.3.4 PROTEINS 102
7.3.5 OTHERS 103
7.4 OTHER CHEMICALS 104
?
8 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION 105
8.2 INTRODUCTION 106
8.3 ORAL FORMULATIONS 107
8.3.1 TABLETS 110
8.3.2 CAPSULES 111
8.3.2.1 Hard Gelatin Capsules 112
8.3.2.2 Soft Gelatin Capsules 114
8.3.3 LIQUID FORMULATIONS 116
8.4 TOPICAL FORMULATIONS 117
8.5 PARENTERAL FORMULATIONS 119
8.6 ADVANCED DELIVERY SYSTEMS 121
9 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 123
9.1 INTRODUCTION 124
9.1.1 FILLERS and DILUENTS 125
9.1.2 BINDERS 127
9.1.3 SUSPENSION and VISCOSITY AGENTS 128
9.1.4 COATINGS 129
9.1.5 FLAVORING AGENTS 130
9.1.6 DISINTEGRANTS 131
9.1.7 COLORANTS 132
9.1.8 LUBRICANTS and GLIDANTS 133
9.1.9 PRESERVATIVES 134
10 GEOGRAPHIC ANALYSIS 136
10.1 INTRODUCTION 137
10.2 NORTH AMERICA 141
10.2.1 U.S. 145
10.2.2 CANADA 148
10.3 EUROPE 150
10.3.1 GERMANY 154
10.3.2 FRANCE 156
10.3.3 U.K. 158
10.3.4 ITALY 161
10.3.5 SPAIN 163
10.3.6 REST OF EUROPE (ROE) 166
10.4 ASIA-PACIFIC (APAC) 169
10.4.1 JAPAN 173
10.4.2 INDIA 175
10.4.3 CHINA 178
10.4.4 REST OF ASIA-PACIFIC (ROAPAC) 180
?
10.5 REST OF THE WORLD (ROW) 183
10.5.1 BRAZIL 186
10.5.2 OTHERS 188
11 COMPETITIVE LANDSCAPE 191
11.1 OVERVIEW 191
11.2 GLOBAL MARKET SHARE ANALYSIS 192
11.2.1 MARKET SHARE ANALYSIS: NORTH AMERICA 194
11.2.2 MARKET SHARE ANALYSIS: EUROPE 194
11.2.3 MARKET SHARE ANALYSIS: APAC 195
11.3 COMPETITIVE SITUATION AND TRENDS 196
11.3.1 EXPANSIONS 197
11.3.2 NEW PRODUCT LAUNCHES 199
11.3.3 MERGERS AND ACQUISITIONS 199
11.3.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, and JOINT VENTURES 200
11.3.5 OTHER DEVELOPMENTS 201
12 COMPANY PROFILES 203
(Overview, Financials, Products and Services, Strategy, and Developments)*
12.1 ASSOCIATED BRITISH FOODS PLC 203
12.2 ARCHER DANIELS MIDLAND COMPANY (ADM) 205
12.3 ASHLAND, INC. 208
12.4 BASF SE 212
12.5 CRODA INTERNATIONAL PLC 215
12.6 THE DOW CHEMICAL COMPANY 220
12.7 EVONIK INDUSTRIES AG 224
12.8 FMC CORPORATION 227
12.9 LUBRIZOL CORPORATION 231
12.10 ROQUETTE 233
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
13 APPENDIX 237
13.1 INSIGHTS OF INDUSTRY EXPERTS 237
13.2 DISCUSSION GUIDE 238
13.3 AVAILABLE CUSTOMIZATIONS 241
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 242
13.5 RELATED REPORTS 243

LIST OF TABLES

TABLE 1 EXPANSIONS THE KEY GROWTH STRATEGY ADOPTED BY MAJORITY OF LEADING PLAYERS 37
TABLE 2 FUNCTIONAL EXCIPIENTS AND PATENT CLIFFS DRIVING MARKET GROWTH 46
TABLE 3 DECLINING RandD INVESTMENTS POSE A LONG-TERM GROWTH BARRIER FOR THE MARKET 48
TABLE 4 SHIFTING FOCUS OF PHARMACEUTICAL MANUFACTURING TO EMERGING COUNTRIES 50
TABLE 5 QUALITY CONCERNS DEMAND GREATER TRANSPARENCY IN SUPPLY CHAIN 51
TABLE 6 MARKETED CO-PROCESSED EXCIPIENTS (2012) 56
TABLE 7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 64
TABLE 8 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 64
TABLE 9 GLOBAL INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 66
TABLE 10 GLOBAL INORGANIC CHEMICALS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 66
TABLE 11 GLOBAL CALCIUM PHOSPHATES MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 67
TABLE 12 GLOBAL CALCIUM CARBONATE MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 68
TABLE 13 GLOBAL CALCIUM SULFATE MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 69
TABLE 14 GLOBAL HALITES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 70
TABLE 15 GLOBAL METALLIC OXIDES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 71
TABLE 16 GLOBAL OTHER INORGANIC CHEMICALS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 72
TABLE 17 GLOBAL ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 73
TABLE 18 GLOBAL ORGANIC CHEMICALS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 74
TABLE 19 GLOBAL CARBOHYDRATES MARKET SIZE, BY PRODUCTS, 2012-2019 ($MILLION) 75
TABLE 20 GLOBAL CARBOHYDRATES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 75
TABLE 21 GLOBAL SUGARS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 76
TABLE 22 GLOBAL SUGARS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 76
TABLE 23 GLOBAL ACTUAL SUGARS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 77
TABLE 24 GLOBAL ACTUAL SUGARS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 77
TABLE 25 GLOBAL SUGAR ALCOHOLS MARKET SIZE, BY PRODUCTS, 2012-2019 ($MILLION) 79
TABLE 26 GLOBAL SUGAR ALCOHOLS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 79
TABLE 27 GLOBAL ARTIFICIAL SWEETENERS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 81
TABLE 28 GLOBAL STARCH MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 81
TABLE 29 GLOBAL STARCH MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 82
TABLE 30 GLOBAL MODIFIED STARCH MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 83
TABLE 31 GLOBAL DRIED STARCH MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 84
TABLE 32 GLOBAL CONVERTED STARCH MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 85
TABLE 33 GLOBAL CELLULOSE MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 86
TABLE 34 GLOBAL CELLULOSE MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 86
TABLE 35 GLOBAL CELLULOSE ETHERS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 87
TABLE 36 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 88
TABLE 37 GLOBAL CELLULOSE ESTERS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 89
TABLE 38 GLOBAL CMC AND CROSCARMELLOSE SODIUM MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 90
TABLE 39 GLOBAL PETROCHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLON) 91
TABLE 40 GLOBAL PETROCHEMICALS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 91
TABLE 41 GLOBAL GLYCOLS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 92
TABLE 42 GLOBAL GLYCOLS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 92
TABLE 43 GLOBAL POVIDONES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 93
TABLE 44 GLOBAL MINERAL HYDROCARBONS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 94
TABLE 45 GLOBAL MINERAL HYDROCARBONS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 94
TABLE 46 GLOBAL ACRYLIC POLYMERS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 96
TABLE 47 GLOBAL OTHER PETROCHEMICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 97
TABLE 48 GLOBAL OLEOCHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 98
TABLE 49 GLOBAL OLEOCHEMICALS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 98
TABLE 50 GLOBAL FATTY ALCOHOLS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 99
TABLE 51 GLOBAL MINERAL STEARATES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 100
TABLE 52 GLOBAL GLYCERIN MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 101
TABLE 53 GLOBAL OTHER OLEOCHEMICAL EXCIPEINTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 102
TABLE 54 GLOBAL PROTEINS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 103
TABLE 55 GLOBAL OTHER ORGANIC CHEMICALS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 103
TABLE 56 GLOBAL OTHER CHEMICALS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 104
TABLE 57 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 107
TABLE 58 RECENT NOVEL EXCIPIENTS FOR ORAL FORMULATIONS 108
TABLE 59 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR ORAL FORMULATIONS, BY TYPE, 2012-2019 ($MILLION) 109
TABLE 60 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR ORAL FORMULATIONS, BY COUNTRY, 2012-2019 ($MILLION) 109
TABLE 61 TYPICAL COMPOSITION OF TABLETS 110
TABLE 62 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR TABLET FORMULATIONS, BY TYPE, 2012-2019 ($MILLION) 110
TABLE 63 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR TABLET FORMULATIONS, BY COUNTRY, 2012-2019 ($MILLION) 111
TABLE 64 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR CAPSULE FORMULATIONS, BY TYPE, 2012-2019 ($MILLION) 112
TABLE 65 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR CAPSULE FORMULATIONS, BY COUNTRY, 2012-2019 ($MILLION) 112
TABLE 66 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR HARD GELATIN CAPSULE FORMULATIONS, BY TYPE, 2012-2019 ($MILLION) 113
TABLE 67 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR HARD GELATIN CAPSULE FORMULATIONS, BY COUNTRY, 2012-2019 ($MILLION) 114
TABLE 68 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR SOFT GELATIN CAPSULE FORMULATIONS, BY TYPE, 2012-2019 ($MILLION) 115
TABLE 69 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR SOFT GELATIN CAPSULE FORMULATIONS, BY COUNTRY, 2012-2019 ($MILLION) 115
TABLE 70 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR ORAL LIQUID FORMULATIONS, BY TYPE, 2012-2019 ($MILLION) 116
TABLE 71 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR ORAL LIQUID FORMULATIONS, BY GEOGRAPHY, 2012-2019 ($MILLION) 116
TABLE 72 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR TOPICAL FORMULATIONS, BY TYPE, 2012-2019 ($MILLION) 118
TABLE 73 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR TOPICAL FORMULATIONS, BY COUNTRY, 2012-2019 ($MILLION) 118
TABLE 74 TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS 119
TABLE 75 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR PARENTERAL FORMULATIONS, BY TYPE, 2012-2019 ($MILLION) 120
TABLE 76 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2012-2019 ($MILLION) 120
TABLE 77 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR ADVANCED FORMULATIONS, BY TYPE, 2012-2019 ($MILLION) 121
TABLE 78 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE FOR ADVANCED DELIVERY SYSTEMS, BY COUNTRY, 2012-2019 ($MILLION) 122
TABLE 79 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 125
TABLE 80 GLOBAL PHARMACEUTICAL FILLERS and DILUENTS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 127
TABLE 81 GLOBAL PHARMACEUTICAL BINDERS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 128
TABLE 82 GLOBAL PHARMACEUTICAL SUSPENSION and VISCOSITY AGENTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 129
TABLE 83 GLOBAL PHARMACEUTICAL COATINGS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 130
TABLE 84 GLOBAL PHARMACEUTICAL FLAVORING AGENTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 131
TABLE 85 GLOBAL PHARMACEUTICAL DISINTEGRANTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 132
TABLE 86 GLOBAL PHARMACEUTICAL COLORANTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 133
TABLE 87 GLOBAL PHARMACEUTICAL LUBRICANTS and GLIDANTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 134
TABLE 88 GLOBAL PHARMACEUTICAL PRESERVATIVES MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 135
TABLE 89 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 140
TABLE 90 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 143
TABLE 91 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 143
TABLE 92 NORTH AMERICA: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 143
TABLE 93 NORTH AMERICA: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 144
TABLE 94 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 144
TABLE 95 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE,
BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 145
TABLE 96 U.S.: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 146
TABLE 97 U.S.: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 146
TABLE 98 U.S.: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 146
TABLE 99 U.S.: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 147
TABLE 100 U.S.: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 147
TABLE 101 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 148
TABLE 102 CANADA: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 148
TABLE 103 CANADA.: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 149
TABLE 104 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 149
TABLE 105 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 150
TABLE 106 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 151
TABLE 107 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 152
TABLE 108 EUROPE: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 152
TABLE 109 EUROPE: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 152
TABLE 110 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 153
TABLE 111 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 153
TABLE 112 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 154
TABLE 113 GERMANY: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 154
TABLE 114 GERMANY: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 155
TABLE 115 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 155
TABLE 116 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 156
TABLE 117 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 156
TABLE 118 FRANCE: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 157
TABLE 119 FRANCE: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 157
TABLE 120 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 158
TABLE 121 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 158
TABLE 122 U.K.: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 159
TABLE 123 U.K.: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 159
TABLE 124 U.K.: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 160
TABLE 125 U.K.: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 160
TABLE 126 U.K.: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 161
TABLE 127 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 161
TABLE 128 ITALY: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 162
TABLE 129 ITALY: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 162
TABLE 130 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 163
TABLE 131 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 163
TABLE 132 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 164
TABLE 133 SPAIN: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 164
TABLE 134 SPAIN: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 165
TABLE 135 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 165
TABLE 136 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 166
TABLE 137 ROE: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 166
TABLE 138 ROE: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 167
TABLE 139 ROE: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 167
TABLE 140 ROE: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 168
TABLE 141 ROE: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 168
TABLE 142 APAC: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 171
TABLE 143 APAC: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 171
TABLE 144 APAC: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 171
TABLE 145 APAC: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 172
TABLE 146 APAC: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 172
TABLE 147 APAC: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 173
TABLE 148 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 173
TABLE 149 JAPAN: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 174
TABLE 150 JAPAN: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 174
TABLE 151 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 175
TABLE 152 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 175
TABLE 153 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 176
TABLE 154 INDIA: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 176
TABLE 155 INDIA: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 177
TABLE 156 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 177
TABLE 157 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 178
TABLE 158 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 178
TABLE 159 CHINA: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 179
TABLE 160 CHINA: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 179
TABLE 161 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 180
TABLE 162 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 180
TABLE 163 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 181
TABLE 164 ROAPAC: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 181
TABLE 165 ROAPAC: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 182
TABLE 166 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 182
TABLE 167 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 183
TABLE 168 ROW: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 183
TABLE 169 ROW: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 184
TABLE 170 ROW: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 184
TABLE 171 ROW: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 184
TABLE 172 ROW: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 185
TABLE 173 ROW: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 185
TABLE 174 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 186
TABLE 175 BRAZIL: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 186
TABLE 176 BRAZIL: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 187
TABLE 177 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,
2012-2019 ($MILLION) 187
TABLE 178 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 188
TABLE 179 OTHER REGIONS: PHARMACEUTICAL EXCIPIENTS MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 188
TABLE 180 OTHER REGIONS: ORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 189
TABLE 181 OTHER REGIONS: INORGANIC CHEMICALS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 189
TABLE 182 OTHER REGIONS: PHARMACEUTICAL EXCIPIENTS MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 190
TABLE 183 OTHER REGIONS: PHARMACEUTICAL EXCIPIENTS MARKET SIZE,
BY TYPE OF FORMULATION, 2012-2019 ($MILLION) 190
TABLE 184 GROWTH STRATEGY MATRIX, 2010-2014 192
TABLE 185 EXPANSIONS, 2011-2014 198
TABLE 186 NEW PRODUCT LAUNCHES, 2011-2013 199
TABLE 187 MERGERS AND ACQUISITIONS, 2011-2014 199
TABLE 188 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES,
2012-2014 200
TABLE 189 OTHER DEVELOPMENTS, 2012-2014 202
LIST OF FIGURES

FIGURE 1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION 22
FIGURE 2 RESEARCH METHODOLOGY 25
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 26
FIGURE 4 BOTTOM-UP APPROACH 27
FIGURE 5 TOP-DOWN APPROACH 27
FIGURE 6 DATA TRIANGULATION METHODOLOGY 28
FIGURE 7 EVOLUTION OF PHARMACEUTICAL EXCIPIENTS 33
FIGURE 8 ORGANIC CHEMICALS TO DOMINATE MARKET DURING FORECAST PERIOD 34
FIGURE 9 TOP SEGMENTS OF THE PHARMACEUTICAL EXCIPIENTS MARKET 35
FIGURE 10 OLEOCHEMICALS TO SHOW HIGHEST GROWTH IN FORECAST PERIOD 35
FIGURE 11 ASIA- PACIFIC MARKET TO GROW THE FASTEST IN THE NEXT FIVE YEARS 36
FIGURE 12 MARKET GROWTH ATTRIBUTED TO EXPANDING PHARMACEUTICAL INDUSTRY 38
FIGURE 13 ORGANIC CHEMICALS HOLD OVER HALF OF THE APAC PHARMACEUTICAL EXCIPIENTS MARKET 39
FIGURE 14 U.S. COMMANDS MORE THAN ONE-FOURTH OF THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET 40
FIGURE 15 NORTH AMERICA HOLDS LARGEST SHARE OF THE MARKET 41
FIGURE 16 PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION, BY PRODUCT 44
FIGURE 17 PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION, BY FUNCTIONALITY 44
FIGURE 18 PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION, BY TYPE OF FORMULATION 45
FIGURE 19 GROWTH OF THE GLOBAL PHARMACEUTICALS MARKET BACKED BY FUNCTIONAL EXCIPIENTS 45
FIGURE 20 INCREASED CONSOLIDATION AND FOCUS ON NOVEL EXCIPIENTS ARE THE LEADING TRENDS IN THIS INDUSTRY 52
FIGURE 21 IPEC TOTAL EXCIPIENT CONTROL PROCESS 53
FIGURE 22 PORTER'S FIVE FORCES ANALYSIS 57
FIGURE 23 PHARMACEUTICAL EXCIPIENTS INDUSTRY: VALUE CHAIN 59
FIGURE 24 STRATEGIC BENCHMARKING: GEOGRAPHIC EXPANSION IN HIGH-GROWTH EMERGING MARKETS IS AT THE CENTER STAGE OF ORGANC GROWTH STRATEGIES OF LEADING PLAYERS IN THE MARKET 61
FIGURE 25 ASIA-PACIFIC IS THE MOST LUCRATIVE MARKET FOR PHARMACEUTICAL EXCIPIENTS 63
FIGURE 26 CALCIUM CARBONATE WILL BE THE FASTEST GROWING MARKET FOR INORGANIC CHEMICALS 65
FIGURE 27 ORGANIC CHEMICALS WILL CONTINUE TO DOMINATE THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET WITH MORE THAN 50% OF THE MARKET IN 2019 73
FIGURE 28 ORAL FORMULATIONS WILL CONTINUE TO DOMINATE THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET BY 2019 106
FIGURE 29 ASIA-PACIFIC TO BE A LUCRATIVE MARKET FOR ORAL FORMULATIONS 108
FIGURE 30 TABLETS WILL CONTINUE TO DOMINATE THE ORAL FORMULATIONS MARKET
BY 2019; WHEREAS, HARD GELATIN CAPSULES WILL BE THE FASTEST GROWING MARKET FOR ORAL FORMULATIONS 113
FIGURE 31 TOPICAL FORMULATION WILL BE THE FASTEST GROWING MARKET 117
FIGURE 32 FILLERS AND DILUENTS WILL CONTINUE TO DOMINATE THE PHARMACEUTICAL EXCIPIENTS MARKET IN 2019 124
FIGURE 33 REST OF THE WORLD TO BE A LUCRATIVE MARKET FOR FILLERS AND DILUENTS 126
FIGURE 34 GEOGRAPHIC SNAPSHOT (2013) - RAPID GROWTH MARKETS ARE EMERGING AS NEW HOT SPOTS 138
FIGURE 35 INDIA OFFERS HIGH GROWTH POTENTIAL FOR ALMOST ALL THE PRODUCT CATEGORIES 139
FIGURE 36 HUGE INVESTMENTS IN DEVELOPMENT OF NOVEL DRUGS AND COMPLEX BIOPHARMACEUTICAL PRODUCTS WILL DRIVE NORTH AMERICAN PHARMACEUTICAL EXCIPIENTS MARKET 142
FIGURE 37 GERMANY IS THE MOST LUCRATIVE MARKET FOR PHARMACEUTICAL EXCIPIENTS IN EUROPE 151
FIGURE 38 APAC PHARMACEUTICAL EXCIPIENTS MARKET: INDIA AND CHINA ARE THE MOST LUCRATIVE MARKETS FOR PHARMACEUTICAL EXCIPIENTS 170
FIGURE 39 COMPANIES ADOPTED EXPANSION AS A KEY GROWTH STRATEGY 191
FIGURE 40 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 193
FIGURE 41 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SHARE ANALYSIS, 2013 194
FIGURE 42 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SHARE ANALYSIS, 2013 195
FIGURE 43 APAC: PHARMACEUTICAL EXCIPIENTS MARKET SHARE ANALYSIS, 2013 196
FIGURE 44 BATTLE FOR MARKET SHARE: EXPANSION WAS THE KEY STRATEGY 197
FIGURE 45 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 203
FIGURE 46 ARCHER DANIELS MIDLAND COMPANY (ADM): COMPANY SNAPSHOT 205
FIGURE 47 ASHLAND, INC.: COMPANY SNAPSHOT 208
FIGURE 48 SWOT ANALYSIS 211
FIGURE 49 BASF SE.: COMPANY SNAPSHOT 212
FIGURE 50 SWOT ANALYSIS 215
FIGURE 51 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT 216
FIGURE 52 THE DOW CHEMICAL COMPANY: COMPANY SNAPSHOT 220
FIGURE 53 SWOT ANALYSIS 223
FIGURE 54 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT 224
FIGURE 55 FMC CORPORATION: COMPANY SNAPSHOT 227
FIGURE 56 SWOT ANALYSIS 230
FIGURE 57 ROQUETTE: COMPANY SNAPSHOT 233
FIGURE 58 SWOT ANALYSIS 236

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.